当前位置： SCI文献检索 > NATURE MEDICINE期刊下所有文献 > TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.

TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.

Abstract：

:Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) characterized by localized areas of demyelination. Although the etiology and pathogenesis of MS remain largely unknown, it is generally assumed that immune responses to myelin antigens contribute to the disease process. The exact sequence of events, as well as the molecular mediators that lead to myelin destruction, is yet to be defined. As a potent mediator of inflammation, the cytopathic cytokine, tumor necrosis factor (TNF) has been considered to be a strong candidate in the pathogenesis of MS and its animal model, experimental autoimmune encephalomyelitis (EAE). However, its role in immune-mediated demyelination remains to be elucidated. To determine the contribution of TNF to the pathogenesis of the MS-like disease provoked by the myelin oligodendrocyte glycoprotein (MOG), we have tested mice with an homologous disruption of the gene encoding TNF. Here we report that upon immunization with MOG, mice lacking TNF develop severe neurological impairment with high mortality and extensive inflammation and demyelination. We show further that inactivation of the TNF gene converts MOG-resistant mice to a state of high susceptibility. Furthermore, treatment with TNF dramatically reduces disease severity in both TNF-/- mice and in other TNF+/+ mice highly susceptible to the MOG-induced disease. These findings indicate that TNF is not essential for the induction and expression of inflammatory and demyelinating lesions, and that it may limit the extent and duration of severe CNS pathology.

journal_name

Nat Med

journal_title

Nature medicine

authors

Liu J,Marino MW,Wong G,Grail D,Dunn A,Bettadapura J,Slavin AJ,Old L,Bernard CC

doi

10.1038/nm0198-078

subject

Has Abstract

pub_date

1998-01-01 00:00:00

pages

78-83

issue

1

eissn

1078-8956

issn

1546-170X

journal_volume

4

pub_type

杂志文章

相关文献

NATURE MEDICINE文献大全
  • Vaccines: past, present and future.

    abstract：:The vaccines developed over the first two hundred years since Jenner's lifetime have accomplished striking reductions of infection and disease wherever applied. Pasteur's early approaches to vaccine development, attenuation and inactivation, are even now the two poles of vaccine technology. Today, purification of micr...

    journal_title：Nature medicine

    pub_type： 历史文章,杂志文章

    doi：10.1038/nm1209

    authors： Plotkin SA

    更新日期：2005-04-01 00:00:00

  • Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis.

    abstract：:Given the associations between chronic inflammation and epithelial cancer, we studied susceptibility to skin carcinogenesis in mice deficient for the pro-inflammatory cytokine TNF-alpha (refs. 5,6). TNF-alpha(-/-) mice were resistant to development of benign and malignant skin tumors, whether induced by initiation wit...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/10552

    authors： Moore RJ,Owens DM,Stamp G,Arnott C,Burke F,East N,Holdsworth H,Turner L,Rollins B,Pasparakis M,Kollias G,Balkwill F

    更新日期：1999-07-01 00:00:00

  • Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120.

    abstract：:Diabetes, a disease in which the body does not produce or use insulin properly, is a serious global health problem. Gut polypeptides secreted in response to food intake, such as glucagon-like peptide-1 (GLP-1), are potent incretin hormones that enhance the glucose-dependent secretion of insulin from pancreatic beta ce...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/nm1168

    authors： Hirasawa A,Tsumaya K,Awaji T,Katsuma S,Adachi T,Yamada M,Sugimoto Y,Miyazaki S,Tsujimoto G

    更新日期：2005-01-01 00:00:00

  • Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound.

    abstract：:The tumor suppressor p53 inhibits tumor growth primarily through its ability to induce apoptosis. Mutations in p53 occur in at least 50% of human tumors. We hypothesized that reactivation of mutant p53 in such tumors should trigger massive apoptosis and eliminate the tumor cells. To test this, we screened a library of...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/nm0302-282

    authors： Bykov VJ,Issaeva N,Shilov A,Hultcrantz M,Pugacheva E,Chumakov P,Bergman J,Wiman KG,Selivanova G

    更新日期：2002-03-01 00:00:00

  • Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma.

    abstract：:The concentration of human immunodeficiency virus type 1 (HIV-1) particles in blood plasma is very predictive of the subsequent disease course in an infected individual; its measurement has become one of the most important parameters for monitoring clinical status. Steady-state virus levels in plasma reflect a balance...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/5576

    authors： Igarashi T,Brown C,Azadegan A,Haigwood N,Dimitrov D,Martin MA,Shibata R

    更新日期：1999-02-01 00:00:00

  • Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.

    abstract：:We describe results from IMmotion150, a randomized phase 2 study of atezolizumab (anti-PD-L1) alone or combined with bevacizumab (anti-VEGF) versus sunitinib in 305 patients with treatment-naive metastatic renal cell carcinoma. Co-primary endpoints were progression-free survival (PFS) in intent-to-treat and PD-L1+ pop...

    journal_title：Nature medicine

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1038/s41591-018-0053-3

    authors： McDermott DF,Huseni MA,Atkins MB,Motzer RJ,Rini BI,Escudier B,Fong L,Joseph RW,Pal SK,Reeves JA,Sznol M,Hainsworth J,Rathmell WK,Stadler WM,Hutson T,Gore ME,Ravaud A,Bracarda S,Suárez C,Danielli R,Gruenwald V,Ch

    更新日期：2018-06-01 00:00:00

  • Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.

    abstract：:The bromodomain and extraterminal (BET) family of proteins comprises four members-BRD2, BRD3, BRD4 and the testis-specific isoform BRDT-that largely function as transcriptional coactivators and play critical roles in various cellular processes, including the cell cycle, apoptosis, migration and invasion. BET proteins ...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/nm.4378

    authors： Dai X,Gan W,Li X,Wang S,Zhang W,Huang L,Liu S,Zhong Q,Guo J,Zhang J,Chen T,Shimizu K,Beca F,Blattner M,Vasudevan D,Buckley DL,Qi J,Buser L,Liu P,Inuzuka H,Beck AH,Wang L,Wild PJ,Garraway LA,Rubin MA,Barb

    更新日期：2017-09-01 00:00:00

  • A new role for Nogo as a regulator of vascular remodeling.

    abstract：:Although Nogo-A has been identified in the central nervous system as an inhibitor of axonal regeneration, the peripheral roles of Nogo isoforms remain virtually unknown. Here, using a proteomic analysis to identify proteins enriched in caveolae and/or lipid rafts (CEM/LR), we show that Nogo-B is highly expressed in cu...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/nm1020

    authors： Acevedo L,Yu J,Erdjument-Bromage H,Miao RQ,Kim JE,Fulton D,Tempst P,Strittmatter SM,Sessa WC

    更新日期：2004-04-01 00:00:00

  • The activated conformation of integrin β7 is a novel multiple myeloma-specific target for CAR T cell therapy.

    abstract：:Cancer-specific cell-surface antigens are ideal targets for monoclonal antibody (mAb)-based immunotherapy but are likely to have previously been identified in transcriptome or proteome analyses. Here, we show that the active conformer of an integrin can serve as a specific therapeutic target for multiple myeloma (MM)....

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/nm.4431

    authors： Hosen N,Matsunaga Y,Hasegawa K,Matsuno H,Nakamura Y,Makita M,Watanabe K,Yoshida M,Satoh K,Morimoto S,Fujiki F,Nakajima H,Nakata J,Nishida S,Tsuboi A,Oka Y,Manabe M,Ichihara H,Aoyama Y,Mugitani A,Nakao T,Hino M,

    更新日期：2017-12-01 00:00:00

  • gammadelta T cells provide a breath of fresh air for asthma research.

    abstract：:gammadelta T cells downregulate airways responsiveness to allergen challenge, possibly by controlling the 'repair' response of the airway epithelium to alphabeta T cell-mediated damage (pages 1150-1156). ...

    journal_title：Nature medicine

    pub_type： 评论,新闻

    doi：10.1038/13447

    authors： Holt PG,Sly PD

    更新日期：1999-10-01 00:00:00

  • A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients.

    abstract：:Natalizumab (NZM), a humanized monoclonal IgG4 antibody to α4 integrins, is used to treat patients with relapsing-remitting multiple sclerosis (MS)1,2, but in about 6% of the cases persistent neutralizing anti-drug antibodies (ADAs) are induced leading to therapy discontinuation3,4. To understand the basis of the ADA ...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/s41591-019-0568-2

    authors： Cassotta A,Mikol V,Bertrand T,Pouzieux S,Le Parc J,Ferrari P,Dumas J,Auer M,Deisenhammer F,Gastaldi M,Franciotta D,Silacci-Fregni C,Fernandez Rodriguez B,Giacchetto-Sasselli I,Foglierini M,Jarrossay D,Geiger R,Sallusto

    更新日期：2019-09-01 00:00:00

  • Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition.

    abstract：:Cells that are deficient in homologous recombination, such as those that lack functional breast cancer-associated 1 (BRCA1) or BRCA2, are hypersensitive to inhibition of poly(ADP-ribose) polymerase (PARP). However, BRCA-deficient tumors represent only a small fraction of adult cancers, which might restrict the therape...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/nm.2377

    authors： Johnson N,Li YC,Walton ZE,Cheng KA,Li D,Rodig SJ,Moreau LA,Unitt C,Bronson RT,Thomas HD,Newell DR,D'Andrea AD,Curtin NJ,Wong KK,Shapiro GI

    更新日期：2011-06-26 00:00:00

  • Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity.

    abstract：:Immune sensing of a microbe occurs via multiple receptors. How signals from different receptors are coordinated to yield a specific immune response is poorly understood. We show that two pathogen recognition receptors, Toll-like receptor 2 (TLR2) and dectin-1, recognizing the same microbial stimulus, stimulate distinc...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/nm.1925

    authors： Manicassamy S,Ravindran R,Deng J,Oluoch H,Denning TL,Kasturi SP,Rosenthal KM,Evavold BD,Pulendran B

    更新日期：2009-04-01 00:00:00

  • Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays.

    abstract：:Naturally occurring mutations in HIV-1-infected patients have important implications for therapy and the outcome of clinical studies. However, little is known about the prevalence of mutations that confer resistance to HIV-1 protease inhibitors in isolates derived from patients naive for such inhibitors. In the first ...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/nm0796-753

    authors： Kozal MJ,Shah N,Shen N,Yang R,Fucini R,Merigan TC,Richman DD,Morris D,Hubbell E,Chee M,Gingeras TR

    更新日期：1996-07-01 00:00:00

  • The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy.

    abstract：:Epigenetic reprogramming is a critical process of pathological gene induction during cardiac hypertrophy and remodeling, but the underlying regulatory mechanisms remain to be elucidated. Here we identified a heart-enriched long noncoding (lnc)RNA, named cardiac-hypertrophy-associated epigenetic regulator (Chaer), whic...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/nm.4179

    authors： Wang Z,Zhang XJ,Ji YX,Zhang P,Deng KQ,Gong J,Ren S,Wang X,Chen I,Wang H,Gao C,Yokota T,Ang YS,Li S,Cass A,Vondriska TM,Li G,Deb A,Srivastava D,Yang HT,Xiao X,Li H,Wang Y

    更新日期：2016-10-01 00:00:00

  • SOCS-3 regulates onset and maintenance of T(H)2-mediated allergic responses.

    abstract：:Members of the suppressor of cytokine signaling (SOCS) family are involved in the pathogenesis of many inflammatory diseases. SOCS-3 is predominantly expressed in T-helper type 2 (T(H)2) cells, but its role in T(H)2-related allergic diseases remains to be investigated. In this study we provide a strong correlation bet...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/nm896

    authors： Seki Y,Inoue H,Nagata N,Hayashi K,Fukuyama S,Matsumoto K,Komine O,Hamano S,Himeno K,Inagaki-Ohara K,Cacalano N,O'Garra A,Oshida T,Saito H,Johnston JA,Yoshimura A,Kubo M

    更新日期：2003-08-01 00:00:00

  • Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis.

    abstract：:Immunization of transgenic mouse models of Alzheimer disease using amyloid-beta peptide (Abeta) reduces both the Alzheimer disease-like neuropathology and the spatial memory impairments of these mice. However, a therapeutic trial of immunization with Abeta42 in humans was discontinued because a few patients developed ...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/nm790

    authors： McLaurin J,Cecal R,Kierstead ME,Tian X,Phinney AL,Manea M,French JE,Lambermon MH,Darabie AA,Brown ME,Janus C,Chishti MA,Horne P,Westaway D,Fraser PE,Mount HT,Przybylski M,St George-Hyslop P

    更新日期：2002-11-01 00:00:00

  • Wireless bioresorbable electronic system enables sustained nonpharmacological neuroregenerative therapy.

    abstract：:Peripheral nerve injuries represent a significant problem in public health, constituting 2-5% of all trauma cases1. For severe nerve injuries, even advanced forms of clinical intervention often lead to incomplete and unsatisfactory motor and/or sensory function2. Numerous studies report the potential of pharmacologica...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/s41591-018-0196-2

    authors： Koo J,MacEwan MR,Kang SK,Won SM,Stephen M,Gamble P,Xie Z,Yan Y,Chen YY,Shin J,Birenbaum N,Chung S,Kim SB,Khalifeh J,Harburg DV,Bean K,Paskett M,Kim J,Zohny ZS,Lee SM,Zhang R,Luo K,Ji B,Banks A,Lee HM,Hua

    更新日期：2018-12-01 00:00:00

  • An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer.

    abstract：:The principles that govern the evolution of tumors exposed to targeted therapy are poorly understood. Here we modeled the selection and propagation of an amplification in the BRAF oncogene (BRAFamp) in patient-derived tumor xenografts (PDXs) that were treated with a direct inhibitor of the kinase ERK, either alone or ...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/nm.4369

    authors： Xue Y,Martelotto L,Baslan T,Vides A,Solomon M,Mai TT,Chaudhary N,Riely GJ,Li BT,Scott K,Cechhi F,Stierner U,Chadalavada K,de Stanchina E,Schwartz S,Hembrough T,Nanjangud G,Berger MF,Nilsson J,Lowe SW,Reis-Filho JS

    更新日期：2017-08-01 00:00:00

  • Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells.

    abstract：:The BTB/POZ transcriptional repressor and candidate oncogene BCL6 is frequently misregulated in B-cell lymphomas. The interface through which the BCL6 BTB domain mediates recruitment of the SMRT, NCoR and BCoR corepressors was recently identified. To determine the contribution of this interface to BCL6 transcriptional...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/nm1134

    authors： Polo JM,Dell'Oso T,Ranuncolo SM,Cerchietti L,Beck D,Da Silva GF,Prive GG,Licht JD,Melnick A

    更新日期：2004-12-01 00:00:00

  • Cidea is an essential transcriptional coactivator regulating mammary gland secretion of milk lipids.

    abstract：:Adequate lipid secretion by mammary glands during lactation is essential for the survival of mammalian offspring. However, the mechanism governing this process is poorly understood. Here we show that Cidea is expressed at high levels in lactating mammary glands and its deficiency leads to premature pup death as a resu...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/nm.2614

    authors： Wang W,Lv N,Zhang S,Shui G,Qian H,Zhang J,Chen Y,Ye J,Xie Y,Shen Y,Wenk MR,Li P

    更新日期：2012-01-15 00:00:00

  • Mutations in G protein β subunits promote transformation and kinase inhibitor resistance.

    abstract：:Activating mutations in genes encoding G protein α (Gα) subunits occur in 4-5% of all human cancers, but oncogenic alterations in Gβ subunits have not been defined. Here we demonstrate that recurrent mutations in the Gβ proteins GNB1 and GNB2 confer cytokine-independent growth and activate canonical G protein signalin...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/nm.3751

    authors： Yoda A,Adelmant G,Tamburini J,Chapuy B,Shindoh N,Yoda Y,Weigert O,Kopp N,Wu SC,Kim SS,Liu H,Tivey T,Christie AL,Elpek KG,Card J,Gritsman K,Gotlib J,Deininger MW,Makishima H,Turley SJ,Javidi-Sharifi N,Maciejewski

    更新日期：2015-01-01 00:00:00

  • A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis.

    abstract：:We report the involvement of an evolutionarily conserved set of mycobacterial genes, the esx-3 region, in evasion of bacterial killing by innate immunity. Whereas high-dose intravenous infections of mice with the rapidly growing mycobacterial species Mycobacterium smegmatis bearing an intact esx-3 locus were rapidly l...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/nm.2420

    authors： Sweeney KA,Dao DN,Goldberg MF,Hsu T,Venkataswamy MM,Henao-Tamayo M,Ordway D,Sellers RS,Jain P,Chen B,Chen M,Kim J,Lukose R,Chan J,Orme IM,Porcelli SA,Jacobs WR Jr

    更新日期：2011-09-04 00:00:00

  • TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity.

    abstract：:We formulate a two-phase paradigm of autoimmunity associated with systemic lupus erythematosus, the archetypal autoimmune disease. The initial Toll-like receptor (TLR)-independent phase is mediated by dendritic cell uptake of apoptotic cell debris and associated nucleic acids, whereas the subsequent TLR-dependent phas...

    journal_title：Nature medicine

    pub_type： 杂志文章,评审

    doi：10.1038/nm1590

    authors： Baccala R,Hoebe K,Kono DH,Beutler B,Theofilopoulos AN

    更新日期：2007-05-01 00:00:00

  • Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts.

    abstract：:It is estimated that 350 million individuals worldwide suffer from rare diseases, which are predominantly caused by mutation in a single gene1. The current molecular diagnostic rate is estimated at 50%, with whole-exome sequencing (WES) among the most successful approaches2-5. For patients in whom WES is uninformative...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/s41591-019-0457-8

    authors： Frésard L,Smail C,Ferraro NM,Teran NA,Li X,Smith KS,Bonner D,Kernohan KD,Marwaha S,Zappala Z,Balliu B,Davis JR,Liu B,Prybol CJ,Kohler JN,Zastrow DB,Reuter CM,Fisk DG,Grove ME,Davidson JM,Hartley T,Joshi R,Stro

    更新日期：2019-06-01 00:00:00

  • Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy.

    abstract：:The cardiac response to increased work includes a reactivation of fetal genes. The response to a decrease in cardiac work is not known. Such information is of clinical interest, because mechanical unloading can improve the functional capacity of the failing heart. We compared here the patterns of gene expression in un...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/3253

    authors： Depre C,Shipley GL,Chen W,Han Q,Doenst T,Moore ML,Stepkowski S,Davies PJ,Taegtmeyer H

    更新日期：1998-11-01 00:00:00

  • Vitamin E decreases bone mass by stimulating osteoclast fusion.

    abstract：:Bone homeostasis is maintained by the balance between osteoblastic bone formation and osteoclastic bone resorption. Osteoclasts are multinucleated cells that are formed by mononuclear preosteoclast fusion. Fat-soluble vitamins such as vitamin D are pivotal in maintaining skeletal integrity. However, the role of vitami...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/nm.2659

    authors： Fujita K,Iwasaki M,Ochi H,Fukuda T,Ma C,Miyamoto T,Takitani K,Negishi-Koga T,Sunamura S,Kodama T,Takayanagi H,Tamai H,Kato S,Arai H,Shinomiya K,Itoh H,Okawa A,Takeda S

    更新日期：2012-03-04 00:00:00

  • Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance.

    abstract：:Oral administration of protein can induce antigen-specific immune hyporesponsiveness. However, the utility of oral tolerance to autoantigens in the treatment of autoimmune diseases may be limited when candidate autoantigens cannot be produced by conventional systems in quantities sufficient for clinical studies. Plant...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/nm0797-793

    authors： Ma SW,Zhao DL,Yin ZQ,Mukherjee R,Singh B,Qin HY,Stiller CR,Jevnikar AM

    更新日期：1997-07-01 00:00:00

  • Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing.

    abstract：:With the goal of modeling human disease of the large intestine, we sought to develop an effective protocol for deriving colonic organoids (COs) from differentiated human embryonic stem cells (hESCs) or induced pluripotent stem cells (iPSCs). Extensive gene and immunohistochemical profiling confirmed that the derived C...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/nm.4355

    authors： Crespo M,Vilar E,Tsai SY,Chang K,Amin S,Srinivasan T,Zhang T,Pipalia NH,Chen HJ,Witherspoon M,Gordillo M,Xiang JZ,Maxfield FR,Lipkin S,Evans T,Chen S

    更新日期：2017-07-01 00:00:00

  • Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy.

    abstract：:Overexpression of the B7-H1 (PD-L1) molecule in the tumor microenvironment (TME) is a major immune evasion mechanism in some patients with cancer, and antibody blockade of the B7-H1/PD-1 interaction can normalize compromised immunity without excessive side-effects. Using a genome-scale T cell activity array, we identi...

    journal_title：Nature medicine

    pub_type： 杂志文章

    doi：10.1038/s41591-019-0374-x

    authors： Wang J,Sun J,Liu LN,Flies DB,Nie X,Toki M,Zhang J,Song C,Zarr M,Zhou X,Han X,Archer KA,O'Neill T,Herbst RS,Boto AN,Sanmamed MF,Langermann S,Rimm DL,Chen L

    更新日期：2019-04-01 00:00:00